whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin
November 2012
You'll hear controversy over whether EVERY patient with type 2 diabetes should take an ACE inhibitor or ARB, aspirin, and statin.
This push is partly due to insurer pay-for-performance programs.
These drugs are often helpful...but watch for the exceptions.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote